Skip to content

Testing Parasternal Intercostal Block for Pain Relief After Heart Surgery at SMS Hospital, Jaipur

A Randomized Controlled Study for The Efficacy Of Parasternal Intercostal Block For Perioperative Analgesia In Cardiac Surgery at SMS Hospital, Jaipur - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068774
Enrollment
76
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

Intervention1: Usg guided Parasternal Intercostal Block: Group A Parasternal intercostal group n 40 Patients undergoing cardiac surgery under GA and receiving bilateral US guided parasternal interco

Sponsors

Sawai Mansingh Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient giving informed written consent 2 All patients between the age group 18-60 years of age scheduled for planned cardiac surgery. 3 ASA grade II & III

Exclusion criteria

Exclusion criteria: 1 Skin infection at the puncture site. 2 Allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
To assess the difference in opioid requirement during cardiac surgery between the two group To assess the difference in post operative VAS between the two groups Timepoint: assessed immediately,2, 4, 6,12,18,24,30,36,42 and 48 hr post extubation.

Secondary

MeasureTime frame
To assess the difference in Haemodynamic stability between two groups To assess the difference in total opioid requirement in 48 hrsTo assess the difference in Haemodynamic stability between two groups To assess the difference in total opioid requirement in 48 hrs. To assess the difference in postoperative pulmonary function Side effects if any To assess the difference in postoperative pulmonary function Side effects if any Timepoint: assessed immediately,2, 4, 6,12,18,24,30,36,42 & 48 hr post extubation.

Countries

India

Contacts

Public ContactDr jitendra kumar bairwa

Sawai Mansingh Medical College and Hospital,Jaipur

reemadr.rn@gmail.com9413237117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026